Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Policy & Legislation

The Mis-Match that Prevents Thousands of MDs from Working

Posted on March 17, 2022March 21, 2022 by Devon Herrick

Imagine spending eight years after high school studying for your dream career. You apply to every medical school you can think of. If you don’t get into a cheaper state school, you apply to more expensive private medical schools. Some aspiring physicians even apply to schools in other countries. When you finally graduate you must then apply for graduate medical education (GME) training programs, which are required before you can practice medicine in all 50 states.

+

Did the Government Make us Fat?

Posted on March 17, 2022March 21, 2022 by John C. Goodman

There is a new study at the Goodman Institute website that makes fascinating reading. Author Greg Rehmke writes:

Saturated fat as the major cause of obesity, diabetes, and cardiovascular disease in the U.S. and around the world. They promoted a low-fat diet with increased consumption of carbohydrates instead. Obesity in the US has been steadily increasing ever since.

+

The Top 10 Health Care Scams of 2021

Posted on March 10, 2022March 21, 2022 by Devon Herrick

The Lown Institute recently released its Top 10 worse examples of profiteering and dysfunction in our health care system in 2021. Lown’s so-called Shkreli Awards were named after Martin Shkreli, the “pharma bro,” whose company became infamous for price gouging. After Turing Pharmaceuticals bought the 60-year old drug Daraprim, the price rose for $13.50 a pill to $750 a…

+
  • Previous
  • 1
  • …
  • 55
  • 56
  • 57
  • 58

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom